The Co-STAR trial tested the performance of colchicine in preventing new-onset arrhythmias and subclinical leaflet thrombosis ...

A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

Spirulina is a nutrient-dense cyanobacterium rich in proteins, phycobiliproteins, carotenoids, and polyphenols that deliver ...

Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for patients with overweight or obesity in an early study, researchers reported.

As previously announced, the pre-planned interim analysis for 2-week safety results from the ongoing Phase 2a biomarker study demonstrated GRI-0621 (4.5mg orally once daily) to be safe and ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety ...

Previous studies have shown that obesity impairs the anti-inflammatory functions of adipose stem cells. Adnan hypothesized that these functions would be restored following weight loss, but the ...

The Pelvic Inflammatory Disease Evaluation and Clinical Health Randomized Trial (PEACH) provides the best guidance regarding the antibiotic therapy of women with mild-to-moderate PID.

Explore the 10 best anti-inflammatory supplements reviewed by RDs. From joint support to heart health, these expert-approved picks are worth trying in 2025.

You don’t need to spend a lot of money to enjoy anti-inflammatory foods. This nutrient-dense snack from Aldi packs omega-3s, fiber and antioxidants in every handful.

Octocoral diterpenoids have shown anti-cancer and anti-inflammatory properties as well, but have chemical structures unlike anything seen on land, making them exciting prospects.